"Wir führen mehr als 5000 katheterinterventionelle Verfahren beispielsweise bei Koronarsyndromen, komplexen Rhythmusstörungen, Valvuloplastien und Schrittmachertherapien durch. Die Herzinsuffizienz und Herztransplantations-Ambulanz ist an das Kompetenznetzwerk Herzinsuffizienz des Bundesministeriums für Bildung und Forschung (BMBF) angeschlossen. Im Rahmen der internistischen Intensivmedizin betreuen wir alle Krankheitsbilder dieses Bereichs. Die Klinik ist Zuweisungszentrum für instabile Koronarsyndrome mit der Möglichkeit der sofortigen interventionellen kardiologischen Therapie. In Spezialambulanzen bieten wir innovative Therapiekonzepte an"

During the past decade, Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" #1 sponsor was "University Hospital, Saarland" with 6 trials, followed by "Ablative Solutions, Inc." with 1 trials sponsored, "Cibiem, Inc." with 1 trials sponsored, "Heart Centre Rotenburg" with 1 trials sponsored and "InnoRa GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" #1 collaborator was "B. Braun Melsungen AG" with 2 trials as a collaborator, "B.Braun Vascular Systems, Berlin, Germany" with 1 trials as a collaborator and "Clinical Research Institute, Center for Cardiovascular Disease Rotenburg a.d.F." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" are "Coronary Artery Disease" (3 trials), "Coronary Restenosis" (2 trials), "Coronary Heart Disease" (1 trials), "Coronary Stenosis" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" in a lesser frequency.

Most popular intervention types in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" are "Device" (10 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel coated balloon catheter (device with drug)" (2 trials), "Catheter-Based Carotid Body Ablation" (1 trials), "DEBlue stent vs. Cypher stent" (1 trials), "DEBlue vs Cypher vs BMS" (1 trials) and "Drug Eluting Balloon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".